In an unusual move, eyeforpharma have just announced that anyone registering for either the Pharma Marketing or the Early Commercialisation, Lifecycle and Portfolio Management Congress will be able to attend the other co-located conference for free. They both take place October 25-26 2007 in Barcelona. This means product, brand and marketing manager or directors are able to get both the high-level strategic knowledge for linear management of their drugs and the case-study driven, campaign centered information they need to improve day-to-day marketing activities. They will be assured a fully comprehensive, 360 degree programme to address their immediate and long-term needs. Delegates can now tap the resources of 45 speakers, 7 sessions, 3 workshops and 11 roundtables. With 130 registered attendees already, the conference promises to be as big and successful as last year; with the amount of knowledge shared almost equaling the proportions of its bigger sibling, SFE.
Further news and updates are available on the conference website www.eyeforpharma.com/marketing07
About eyeforpharma
eyeforpharma is a leading global source of information for the pharmaceutical industry. Our reputation has been built on quality, in-depth conferences that have distinguished themselves from competitors by the depth and breadth of research we put into each conference to ensure it is covering the hottest and most pertinent issues of the industry. Months are spent talking directly to senior executives in the industry, as well as relevant consultants and journalists and well respected solutions providers.
eyeforpharma also provides a fortnightly newsletter to over 11 thousand leading executives from every major pharmaceutical company in the industry, and of course consultants, sponsors and academics as well.
The eyeforpharma wiki, launched last month, highlights our dedication to improving the communication between people in the industry and furthering learning and development within it.
For further information, please visit www.eyeforpharma.com.